# Quality Gate Report

## Spec Reference
- **Spec**: `specs/001-add-cross-review-rounds-to-workflows/01-spec.md`
- **Implementation Summary**: `specs/001-add-cross-review-rounds-to-workflows/04-implementation-summary.md`
- **Test Report**: `specs/001-add-cross-review-rounds-to-workflows/04-test-report.md`

---

## Test Suite Results

### Run Command
Manual structural inspection of `workflows/patch.md`, `workflows/minor.md`, and `workflows/major.md` against every acceptance criterion in the spec. No automated test suite exists for workflow markdown files; validation is performed by direct reading of the live files.

### Results
- **Total acceptance criteria**: 10
- **Passed**: 10
- **Failed**: 0
- **All tests passing**: YES

---

## Acceptance Criteria Validation

### AC-1: Phase 4 cross-review exists in patch.md

- **Status**: PASS
- **Evidence**: `workflows/patch.md` Phase 4, step 5 (lines 129–135) reads:

  `5. **Cross-review round** - Launch two agents in parallel:`

  Sub-item `a.` launches `software-engineer` in IMPLEMENTATION mode (cross-review): reads `{SPEC_FOLDER}/04-test-report.md` first, then own `{SPEC_FOLDER}/04-implementation-summary.md`, appends `## Cross-Review Notes` to `{SPEC_FOLDER}/04-implementation-summary.md`.

  Sub-item `b.` launches `qa-engineer` in IMPLEMENTATION mode (cross-review): reads `{SPEC_FOLDER}/04-implementation-summary.md` first, then own `{SPEC_FOLDER}/04-test-report.md`, appends `## Cross-Review Notes` to `{SPEC_FOLDER}/04-test-report.md`.

  The step is positioned after step 4 (`**After SE completes, launch \`qa-engineer\` in IMPLEMENTATION mode**`) and before step 6 (`**Read both output documents.**`). This is the correct post-implementation, pre-results position. Former steps 5–8 are renumbered to 6–9 with no gaps or duplicates.

  Both prompts open with `"You are completing a cross-review."` and use `{SPEC_FOLDER}/` path prefixes with backtick-quoted filenames, consistent with the established cross-review pattern.
- **Notes**: Note that the existing quality gate document (now replaced by this report) incorrectly recorded AC-1 as FAIL, apparently written against the pre-PR-1 state of the file. The live file at the time of this quality gate contains the step.

---

### AC-2: Phase 4 cross-review exists in minor.md

- **Status**: PASS
- **Evidence**: `workflows/minor.md` Phase 4, step 5 (lines 226–232) reads:

  `5. **Cross-review round** — Launch two agents in parallel:`

  Sub-item `a.` launches `software-engineer` in IMPLEMENTATION mode (cross-review): reads `{SPEC_FOLDER}/04-test-report.md` first, then own `{SPEC_FOLDER}/04-implementation-summary.md`, appends `## Cross-Review Notes` to `{SPEC_FOLDER}/04-implementation-summary.md`.

  Sub-item `b.` launches `qa-engineer` in IMPLEMENTATION mode (cross-review): reads `{SPEC_FOLDER}/04-implementation-summary.md` first, then own `{SPEC_FOLDER}/04-test-report.md`, appends `## Cross-Review Notes` to `{SPEC_FOLDER}/04-test-report.md`.

  The step is positioned after step 4 (`**After all sub-PRs are implemented**`) and before step 6 (`**Read both output documents.**`). This is the correct post-consolidation, pre-results position specified by the spec. Former steps 5–8 are renumbered to 6–9 with no gaps.

  Both prompts open with `"You are completing a cross-review."` and use em-dash (`—`) in the step label, matching the minor.md formatting convention as used in Phase 2 step 3 and Phase 3 step 3 of the same file.
- **Notes**: The existing quality gate document (now replaced by this report) incorrectly recorded AC-2 as FAIL, written against the pre-PR-1 state of the file. The live file at the time of this quality gate contains the step.

---

### AC-3: Phase 4 cross-review exists in major.md

- **Status**: PASS
- **Evidence**: `workflows/major.md` Phase 4, step 5 (lines 288–300) reads:

  `5. **Cross-review round** — Launch agents in parallel (2 or 4):`

  Four lettered sub-items are present:
  - `a.` `software-engineer` in IMPLEMENTATION mode (cross-review): reads `04-test-report.md`, appends `## Cross-Review Notes` to `04-implementation-summary.md`.
  - `b.` `qa-engineer` in IMPLEMENTATION mode (cross-review): reads `04-implementation-summary.md`, appends `## Cross-Review Notes` to `04-test-report.md`.
  - `c.` `software-architect` in IMPLEMENTATION mode (cross-review) **(only if activated)**: reads `04-infra-summary.md`, appends `## Cross-Review Notes` to `04-implementation-summary.md`.
  - `d.` `devops-engineer` in IMPLEMENTATION mode (cross-review) **(only if activated)**: reads `04-implementation-summary.md`, appends `## Cross-Review Notes` to `04-infra-summary.md`.

  The step is placed after step 4 (`**After all sub-PRs are implemented**`) and before step 6 (`**Present results**`). Former steps 5 and 6 are renumbered to 6 and 7. The `(2 or 4)` agent count in the label correctly reflects the variable count when DevOps is or is not active.
- **Notes**: The SA and DevOps sub-items carry `(only if activated)` labels, correctly limiting their participation to when the DevOps Engineer has been activated. The two `## Cross-Review Notes` sections that will appear in `04-implementation-summary.md` (one from SE via step 5a, one from SA via step 5c) are intentional — both agents are instructed to append to the same document. This mirrors how `05-quality-gate.md` accumulates multiple named sections from multiple agents in Phase 5.

---

### AC-4: Phase 4 cross-review prompts match the Discovery/Planning pattern

- **Status**: PASS
- **Evidence**: All new Phase 4 cross-review prompts across all three workflow files satisfy the four required elements:
  1. Opens with `"You are completing a cross-review."` — confirmed in all six SE/QA sub-items across patch.md, minor.md, and major.md Phase 4, and in both SA/DevOps sub-items in major.md Phase 4 and Phase 1.9.
  2. Specifies the peer document to read first — each prompt reads the other agent's document before its own.
  3. Specifies which document to append to — each prompt appends to the agent's own document.
  4. Uses the section heading `## Cross-Review Notes` — confirmed in all new cross-review prompts.

  Document path format `{SPEC_FOLDER}/[filename]` with backtick quoting is used in all new prompts, consistent with all other prompts in the three workflow files.

  The major.md Phase 1.9 step 3 prompts follow the same pattern: SA reads `01-spec-infra-review.md`, appends `## Cross-Review Notes` to `01-spec-arch-review.md`; DevOps reads `01-spec-arch-review.md`, appends `## Cross-Review Notes` to `01-spec-infra-review.md`.
- **Notes**: The patch.md Phase 5 step 3 (AC-6) intentionally opens with `"You are completing a final reflection."` rather than `"You are completing a cross-review."` — this step is a self-reflection by QA after reading the SE's appended review, not a first-read peer cross-review. The spec (AC-6) does not mandate the `cross-review` opening phrase for this step. The divergence is correct and by design.

---

### AC-5: Phase 4 cross-review prompts follow parallel launch pattern

- **Status**: PASS
- **Evidence**:
  - `patch.md` Phase 4 step 5: single numbered step labelled `**Cross-review round** - Launch two agents in parallel:` with two lettered sub-items (`a.`, `b.`). No sequential language.
  - `minor.md` Phase 4 step 5: single numbered step labelled `**Cross-review round** — Launch two agents in parallel:` with two lettered sub-items (`a.`, `b.`). No sequential language.
  - `major.md` Phase 4 step 5: single numbered step labelled `**Cross-review round** — Launch agents in parallel (2 or 4):` with four lettered sub-items (`a.` through `d.`). No sequential language.
  - `major.md` Phase 1.9 step 3: single numbered step labelled `**Cross-review round** — Launch two agents in parallel:` with two lettered sub-items (`a.`, `b.`). No sequential language.

  All cross-review steps use the established parallel launch format (single step number, lettered sub-items, explicit "in parallel" wording), consistent with how Phase 2 and Phase 3 cross-reviews are structured in each file.
- **Notes**: The patch.md Phase 5 step 3 (AC-6) is correctly sequential — it uses "After SE completes..." and has no lettered parallel sub-items. This is mandated by the spec, which states the QA final reflection is "an inherently sequential step."

---

### AC-6: Phase 5 patch QA final reflection step is added

- **Status**: PASS
- **Evidence**: `workflows/patch.md` Phase 5, step 3 (lines 161–162) reads:

  `3. **After SE completes, launch \`qa-engineer\` in QUALITY GATE mode (final reflection)**:`

  Prompt: `"You are completing a final reflection. Read the full quality gate report at \`{SPEC_FOLDER}/05-quality-gate.md\`, including the Software Engineer's '## Software Engineer - Test Quality Review' section. Append a '## QA Engineer - Final Reflection' section to \`{SPEC_FOLDER}/05-quality-gate.md\` acknowledging the SE's test quality findings, noting any updates to your assessment warranted by the SE's observations, and confirming or revising your overall verdict."`

  All five spec requirements for AC-6 are met:
  - Step runs after SE completes step 2: CONFIRMED (`"After SE completes"` prefix, step positioned after step 2).
  - QA reads full `05-quality-gate.md` including SE's section: CONFIRMED (prompt explicitly names the SE's `## Software Engineer - Test Quality Review` section).
  - Section heading is exactly `## QA Engineer - Final Reflection`: CONFIRMED.
  - QA can update verdict: CONFIRMED ("confirming or revising your overall verdict").
  - Step is sequential, not parallel: CONFIRMED (single agent, no lettered sub-items, sequential prefix).

  Phase 5 step numbering is now: step 1 (QA launch), step 2 (SE launch), step 3 (new QA final reflection), step 4 (Read quality gate report — renumbered from 3), step 5 (Present results — renumbered from 4), step 6 (Handle verdict — renumbered from 5). Sequential numbering 1–6 with no gaps.

---

### AC-7: Phase 1.7/1.9 SA↔DevOps cross-review exists in major.md (when DevOps is active)

- **Status**: PASS
- **Evidence**: `workflows/major.md` Phase 1.9 `### Steps (only if activated):` block, step 3 (lines 98–104) reads:

  `3. **Cross-review round** — Launch two agents in parallel:`

  Sub-item `a.`: `software-architect` in SPEC REVIEW mode (cross-review) — reads `{SPEC_FOLDER}/01-spec-infra-review.md` (DevOps's document), then own `{SPEC_FOLDER}/01-spec-arch-review.md`, appends `## Cross-Review Notes` to `{SPEC_FOLDER}/01-spec-arch-review.md`.

  Sub-item `b.`: `devops-engineer` in SPEC REVIEW mode (cross-review) — reads `{SPEC_FOLDER}/01-spec-arch-review.md` (SA's document), then own `{SPEC_FOLDER}/01-spec-infra-review.md`, appends `## Cross-Review Notes` to `{SPEC_FOLDER}/01-spec-infra-review.md`.

  The step is physically inside the `### Steps (only if activated):` block, after step 2 and before the `**Track activation status**` paragraph. Both agents are launched in parallel in a single numbered step with lettered sub-items. Document references are correct: SA reads DevOps's document; DevOps reads SA's document; each appends to their own document.
- **Notes**: The `**Track activation status**` paragraph remains immediately after step 3 as unnumbered bold prose, unchanged from its original position.

---

### AC-8: Phase 1.7/1.9 cross-review is skipped when DevOps is not active

- **Status**: PASS
- **Evidence**: The new step 3 is physically located inside the `### Steps (only if activated):` block of Phase 1.9 (lines 91–106). The `### Activation Check:` block immediately preceding this section (lines 87–90) gates the entire `### Steps (only if activated):` section with the rule: "If empty/'None'/'N/A' → SKIP. Otherwise → ACTIVATE." When the `Affected Areas > Infrastructure` section of the spec is empty or "None," the orchestrator skips to Phase 2 without executing any step in the activated block, including the new step 3.

  No unconditional SA↔DevOps cross-review block was added outside this conditional section. Reading from Phase 1.9 to the Phase 2 heading confirms that only the `**Track activation status**` paragraph and a `---` separator appear between Phase 1.9 step 3 and Phase 2 — no additional cross-review block.
- **Notes**: Conditionality is implemented through block-level placement rather than a per-step guard, consistent with how all other conditional blocks in major.md are gated (Phase 1.5, Phase 1.9 itself, and all `(only if activated)` sub-items in Phase 2 through Phase 4).

---

### AC-9: Workflow document structure remains consistent

- **Status**: PASS
- **Evidence**:
  - **patch.md Phase 4 step 5**: Uses hyphen-dash (` - `) separator in `**Cross-review round** - Launch two agents in parallel:`, matching Phase 2 step 3 and Phase 3 step 3 of patch.md which use the same ` - ` style.
  - **minor.md Phase 4 step 5**: Uses em-dash (`—`) in `**Cross-review round** — Launch two agents in parallel:`, matching Phase 2 step 3 and Phase 3 step 3 of minor.md which also use em-dash.
  - **major.md Phase 1.9 step 3 and Phase 4 step 5**: Both use em-dash (`—`), matching all other cross-review steps in major.md (Phase 2 step 3: `**Cross-review round** — Launch agents in parallel (3-5):`).
  - Agent sub-item format in major.md uses backtick-quoted agent names and `(cross-review)` parenthetical: `**\`software-architect\` in SPEC REVIEW mode (cross-review)**:`, consistent with existing agent sub-item format in the file.
  - Conditional SA/DevOps sub-items in major.md Phase 4 carry `(only if activated)` labels, matching the pattern used for conditional agents in Phase 2 and Phase 3 (e.g., `**\`devops-engineer\` cross-review** (only if activated):`).
  - patch.md Phase 5 step 3 is a standalone numbered step (not a parallel sub-structure), matching the format of adjacent steps 1 and 2. It uses the "After SE completes" prefix consistent with step 2's "After QA completes" prefix.
  - All step numbering across all three files is sequential with no gaps after new insertions.
- **Notes**: The hyphen-dash vs. em-dash variation between patch.md and minor.md/major.md is a pre-existing per-file convention, not a new inconsistency introduced by this change.

---

### AC-10: No existing workflow steps are removed or reordered

- **Status**: PASS
- **Evidence**:

  **patch.md**:
  - Phase 2 step 3 cross-review (SE and QA parallel): intact and unmodified.
  - Phase 3 step 3 cross-review (SE and QA parallel): intact and unmodified.
  - Phase 4 original steps 1–4: intact. Former steps 5–8 renumbered to 6–9 with original content preserved.
  - Phase 5 original steps 1 and 2: intact. Former steps 3–5 renumbered to 4–6 with original content preserved.
  - Phase 6 all six steps: intact and unmodified.

  **minor.md**:
  - Phase 2 and Phase 3 cross-review steps: intact and unmodified.
  - Phase 4 original steps 1–4: intact. Former steps 5–8 renumbered to 6–9 with original content preserved.
  - Phase 5 and Phase 6: intact and unmodified.

  **major.md**:
  - Phase 1.9 original steps 1 and 2: intact at their original numbers. The `**Track activation status**` paragraph is preserved as unnumbered prose immediately after step 3. New step 3 is a pure addition.
  - Phase 2 and Phase 3 cross-review steps (all sub-items a–e): intact and unmodified.
  - Phase 4 original steps 1–4 and the per-phase loop with sub-items a–g: intact. Former steps 5 and 6 renumbered to 6 and 7 with original content preserved.
  - Phase 5 and Phase 6: intact and unmodified.

  No step label text was altered, no steps were removed, and no steps were reordered relative to their peers in any file.

---

## Code Quality Assessment

- **Convention compliance**: All modified files follow the per-file formatting conventions exactly. patch.md uses hyphen-dash (` - `) in cross-review step labels; minor.md and major.md use em-dash (`—`). Agent names are backtick-quoted in all new prompts. Mode names (IMPLEMENTATION, SPEC REVIEW, QUALITY GATE) are consistent with the established vocabulary. Conditional labels `(only if activated)` and `(cross-review)` are applied consistently and match existing usage in the same files.
- **Readability**: New steps are clearly labeled and their position in the workflow is unambiguous. The `(2 or 4)` agent count in major.md Phase 4 step 5 accurately communicates the variable agent count. The `(final reflection)` parenthetical in patch.md Phase 5 step 3 correctly distinguishes it from a standard quality gate launch. Prompt text is concise, actionable, and consistent in voice and structure with existing prompts.
- **Error handling**: Not applicable — workflow markdown files have no runtime error handling. The conditional activation patterns correctly gate the SA↔DevOps cross-review (AC-7 and AC-8) through established block-level placement.
- **No scope creep**: Changes are strictly limited to the five insertion points defined in the spec. No Phase 5 or Phase 6 steps were modified in minor.md or major.md. No agent definition files were touched. No other workflow files were modified.

---

## Test Coverage Assessment

- **Criteria coverage**: All 10 acceptance criteria have tests or structural checks covering them. AC-1, AC-2, and partial coverage of AC-4, AC-5, AC-9, AC-10 (for patch.md and minor.md Phase 4) were validated in the PR 1 session. AC-3, AC-6, AC-7, AC-8, and the major.md/patch.md Phase 5 portions of AC-4, AC-5, AC-9, AC-10 were validated in the PR 2 test report (37 checks, all passing). This quality gate report independently re-validates all 10 against the live files.
- **Edge case coverage**: The test report covers document reference correctness (EC-3, EC-5, EC-6), append-not-overwrite instruction wording (EC-4), the `Track activation status` paragraph positioning (EC-2), and the intentional two-`## Cross-Review Notes`-sections design on `04-implementation-summary.md` (V-4.7).
- **Regression coverage**: All existing Phase 2 and Phase 3 cross-review steps, Phase 5 steps, Phase 6 steps, and original Phase 1.9 and Phase 4 steps across all three workflow files are confirmed intact. The test report's RT-3 through RT-7 regression checks, step-numbering checks, and V-10.4/V-10.5 checks provide comprehensive regression coverage.

---

## Regression Risk

- **Risk level**: low
- **Rationale**: All changes are additive insertions only — no existing workflow instructions were deleted, modified in content, or reordered. Step renumbering was applied correctly and consistently in all affected phases. Step numbers in these workflow files are labels for human readers, not machine-parsed identifiers, so renumbering carries no functional risk to orchestrator execution. All new steps follow the established cross-review pattern that the orchestrator already handles correctly in Phases 2 and 3 of every tier.
- **Areas to monitor**: If any external documentation (onboarding guides, training prompts) references `patch.md Phase 5` steps by number, those references should be updated to reflect the new numbering (the former step 3 `Read the quality gate report` is now step 4, former step 4 `Present results` is now step 5, former step 5 `Handle the verdict` is now step 6). This is a documentation housekeeping concern, not a functional risk.

---

## Blockers

No blockers identified. All 10 acceptance criteria pass in the live files. No regression risk was introduced.

---

## Recommendations

1. **Two `## Cross-Review Notes` sections on `04-implementation-summary.md`**: In major.md Phase 4, both the SE (step 5a) and the SA (step 5c) are instructed to append a `## Cross-Review Notes` section to `04-implementation-summary.md`. This means the document will accumulate two sections with the same heading from two different agents (SE commenting on test alignment, SA commenting on infrastructure alignment). This is intentional and consistent with the multi-agent accumulation pattern in `05-quality-gate.md`. It is worth noting in onboarding materials so future contributors understand this is a deliberate design, not a defect.

2. **Prior quality gate document obsoleted**: The `05-quality-gate.md` that existed before this report was written against the pre-PR-1 state of the workflow files, which caused it to incorrectly record AC-1 and AC-2 as FAIL. This report supersedes that document. Future multi-PR specs should defer quality gate execution until all PRs are confirmed present in the target branch to avoid this class of false negative.

---

## Verdict

### Decision: APPROVED

**Rationale**: All 10 acceptance criteria pass with direct evidence from the live workflow files. The five required insertion points — Phase 4 cross-review in `patch.md` (AC-1), Phase 4 cross-review in `minor.md` (AC-2), Phase 4 cross-review in `major.md` (AC-3), Phase 5 QA final reflection in `patch.md` (AC-6), and Phase 1.9 SA↔DevOps cross-review in `major.md` (AC-7) — are all present, correctly positioned, correctly formatted, and correctly worded. No existing steps were removed or reordered. No scope creep is present. All conditional logic, step numbering, prompt content, and formatting conventions are correct and consistent with established patterns in each workflow file. Regression risk is low. The implementation is complete and ready to merge.

---

## Tech Lead - Architecture Review

### Plan Adherence

- **Followed approved plan**: MOSTLY
- **Deviations**: One deviation between the plan document and the live implementation: `03-plan-se.md` Change 4 was not updated to specify `(only if activated)` as required by the planning review verdict. The plan's Change 4 section (line 179) still contains the original hedge language — "Note: either `(only if DevOps is active)` or `(only if activated)` is acceptable; check the Phase 2 major.md pattern and use exact matching phrasing `(only if activated)` if consistency is preferred." — and the plan's new_string for that change shows `(only if DevOps is active)` in the sub-item labels `c.` and `d.`. However, the live `major.md` file at lines 296–300 correctly uses `(only if activated)` on both sub-items.
- **Deviation assessment**: Partially justified. The implementing agent applied the correct label in the actual workflow file, which is the artifact that matters at runtime. The plan document was not updated as instructed, which is a process deviation. The outcome is correct; only the audit trail is incomplete. The live file is the authoritative artifact and it is correct.

### Architecture Quality

- **Abstractions**: Clean and appropriate. All five insertions operate at exactly the right level — they replicate the nearest existing cross-review step structure within each file, using the correct agents, modes, document references, and prompt phrasing for each context. No new abstractions were introduced or needed.
- **Coupling**: Low (good). Each new cross-review step is self-contained. The only dependency is the document-path convention already established by the surrounding steps in the same file. No cross-file or cross-phase coupling was introduced.
- **Cohesion**: High (good). Each insertion is placed in the correct phase and at the correct position within that phase — after the primary work steps and before the results-presentation step — which is the established pattern for cross-review placement across all three tiers.
- **Dependency direction**: Correct. The read-then-append pattern in each new prompt follows the same direction used in all existing cross-review steps: read the peer's primary document first, then read own primary document, then append to own document. No inversions.

### Convention Compliance

- **Naming**: Follows conventions. Agent names are backtick-quoted throughout (`software-architect`, `devops-engineer`, `software-engineer`, `qa-engineer`). Mode names (IMPLEMENTATION, SPEC REVIEW, QUALITY GATE) match the established vocabulary. Section heading `## Cross-Review Notes` and `## QA Engineer - Final Reflection` match the spec-defined names.
- **Code organization**: Follows patterns. patch.md Phase 4 uses the hyphen-dash separator (`-`), consistent with its Phase 2 and Phase 3 cross-review steps. minor.md and major.md use em-dash (`—`), consistent with their existing cross-review steps. This file-specific convention distinction was an explicit recommendation from the TL discovery review and was correctly applied everywhere.
- **Error handling**: Not applicable for markdown workflow files. Conditionality is applied correctly: the Phase 1.9 step 3 is guarded by block-level placement inside `### Steps (only if activated):`, and the Phase 4 major.md sub-items `c.` and `d.` carry `(only if activated)` labels consistent with Phase 2 step 3e of the same file. Both mechanisms match the existing conditional patterns in `major.md`.

### Tech Debt Introduced

- **New debt**: None.
- **Details**: All five insertions are purely additive and follow established patterns. The `03-plan-se.md` document's Change 4 section retains the pre-required-change hedge language, but this is a documentation artifact in the spec folder, not production workflow code. It does not represent tech debt in the workflow system itself. Future spec readers examining this spec folder should be aware that the live implementation superseded the plan on this specific label.

### Required Changes Follow-up

The planning review verdict was APPROVED WITH CHANGES with one required change:

- **Change 1 (Specify `(only if activated)` as the conditional label in major.md Phase 4 sub-items `c.` and `d.`)**: IMPLEMENTED IN THE LIVE FILE, NOT IN THE PLAN DOCUMENT. The live `major.md` at lines 296 and 299 correctly reads `(only if activated)` on both sub-items, which is the outcome that matters. The `03-plan-se.md` Change 4 section was not revised to remove the hedge language and replace `(only if DevOps is active)` with `(only if activated)` in its new_string. The instruction specified that the SE should update the plan document; this step was skipped. The architectural goal — a consistent `(only if activated)` label in the live workflow file — was achieved.

### Verdict

ADEQUATE

The implementation is architecturally correct. All five insertions are at the right level of abstraction, follow the existing structural and formatting patterns of their respective files, are positioned correctly within the workflow phase sequence, and use the right conditional mechanisms. The required change from the planning review was applied correctly to the live `major.md` file. The only gap is that `03-plan-se.md` was not updated to reflect the resolved label decision as instructed, leaving a minor inconsistency in the spec folder's audit trail. This does not affect the workflow files that agents and orchestrators actually execute.

---

## Software Engineer - Test Quality Review

### Test Correctness

The test report's validation method — structural inspection of the live workflow markdown files — is the correct and only viable approach for this type of change. The subject of the spec is workflow instruction text, not executable code, so there is no runnable test suite to execute. Every check in the report directly reads a specific file, quotes the exact text found, and maps it to a named acceptance criterion. This is thorough and accurate.

The assertions are grounded correctly. Each check verifies the exact artifact the spec requires: presence of a step at a specific position, the exact wording of a prompt, whether a step is sequential or parallel, whether a conditional label is present, and whether document references use the correct path format. The report does not test proxy indicators or infer compliance indirectly — it reads the actual text.

One structural note: the test report is split across two sessions (PR 1 and PR 2), with PR 1 results deferred to a prior session not included in `04-test-report.md`. The report correctly acknowledges this scoping. The quality gate report independently re-validates all 10 acceptance criteria against the live files and reaches the same conclusions, so the absence of PR 1 test detail from the test report file does not create a coverage gap — it is compensated by the quality gate's full re-validation pass. This arrangement is acceptable but creates a fragmented audit trail.

No checks are testing the wrong thing. The V-4.7 check is a notable example of a check that goes beyond simple presence detection: it identifies an intentional design decision (two `## Cross-Review Notes` sections accumulating on `04-implementation-summary.md` from two different agents) and explicitly records it as not a defect. This prevents a future reader from incorrectly flagging it as an error and represents high-quality test documentation practice.

The V-4.9 and V-4.10 checks verify that the Phase 1.9 prompts instruct each agent to read the peer's document first — not their own. This catches a common implementation error in peer cross-review steps (inverting the read order) and is the right thing to verify. The equivalent direction checks appear consistently throughout the report for all new cross-review steps.

### Coverage Adequacy

All 10 acceptance criteria from the spec are covered. Coverage is strong across several dimensions:

- **Content checks**: Every new prompt's required elements are individually verified (V-4.5 through V-4.11, V-6.3). The five required elements of AC-6 are checked one by one against the actual patch.md Phase 5 step 3 text (V-6.1, V-6.2, V-6.3).
- **Structural checks**: Step numbering sequences are verified exhaustively in patch.md Phase 5 (V-NUM.2), major.md Phase 4 (V-NUM.5), and major.md Phase 1.9 (V-NUM.4). There are no numbering gaps or duplicates confirmed across all three locations.
- **Conditionality checks**: The report correctly validates that the SA↔DevOps cross-review in major.md is gated by the Phase 1.9 conditional block (V-8.1, V-8.2), not just that the step exists.
- **Regression checks**: RT-3 through RT-7 cover existing Phase 2 and Phase 3 cross-review steps, Phase 6 steps, and the pre-existing Phase 5 SE step in patch.md. V-10.4 and V-10.5 verify that original Phase 1.9 and Phase 4 steps are intact and unaltered in major.md.
- **Edge cases**: EC-2 through EC-6 cover the `Track activation status` paragraph positioning, document reference correctness, the append-not-overwrite instruction wording in all new prompts, cross-phase document isolation (Phase 1.9 steps do not reference Phase 4 documents, and vice versa), and the intentional two-sections design on `04-implementation-summary.md`.

Two small gaps are worth flagging:

First, there is no explicit regression check in the PR 2 test report confirming that `minor.md` Phase 5 was left unmodified. The spec clearly places adding Phase 5 cross-review to minor.md out of scope, but an explicit check for "minor.md Phase 5 steps intact" would confirm no scope creep occurred there. RT-4 indirectly covers this by confirming minor.md was not touched at all in PR 2, which is sufficient; but the gap exists at the check-naming level.

Second, detail-level prompt content checks for `minor.md` Phase 4 (analogous to V-4.5/V-4.6 for major.md) belong to the PR 1 session record, which is not present in the test report file. The quality gate's AC-2 section fills this gap at the report level, but the symmetry of having equivalent checks per-file and per-criterion is broken in the test report as written.

Neither gap represents a missed acceptance criterion — both are documentation completeness observations.

### Test Quality

The report is well-organized. Checks are grouped logically by acceptance criterion and by type (regression, numbering, formatting, content). Each check has a consistent format — status followed by evidence — and the evidence section always quotes the exact text read from the file rather than paraphrasing, making checks independently verifiable without re-reading the source files.

The naming scheme (V-3.1, V-4.5, RT-3, EC-2, V-NUM.2) is inherited from the test plan and applied consistently. A reader unfamiliar with the plan's check numbering system will need to cross-reference the plan to understand the naming, but within the scope of a single spec this is acceptable.

Assertions are behavioral rather than brittle. Checks verify properties like "step is sequential", "step contains both SE and QA sub-items", "no sequential language is present", and "step appears after step 4 and before step 6" — not fragile things like exact character positions or line numbers. Line numbers are given as orientation context only (e.g., "lines 98–104") rather than as the assertion criterion itself, which means the checks remain valid if surrounding content is reformatted.

The `## Cross-Review Notes` section that the QA engineer appended to the test report after reading the implementation summary is itself a live demonstration that the Phase 4 step 5b prompt (verified by check V-4.6) is correctly worded and actionable. This is an unintentional but real self-validation of the workflow instruction.

No anti-patterns are observed: no flaky conditions, no assertions on implementation details that could change without affecting the spec requirement, no checks that would pass even if the wrong content were present.

### Recommendations

1. **Consolidate PR 1 test results into the test report file.** The current arrangement leaves the PR 1 validation implicit, compensated by the quality gate's independent re-validation. For a clean, self-contained audit trail, PR 1 checks should be included in `04-test-report.md`. Future multi-PR specs should complete test reporting per PR and accumulate results into a single file.

2. **Add an explicit regression check for minor.md Phase 5 being unmodified.** RT-4 covers this implicitly, but a dedicated check named to match the scope ("minor.md Phase 5 steps intact") would make the regression coverage table fully symmetric with the checks for patch.md and major.md.

3. **Add prompt-content detail checks for minor.md Phase 4 to the PR 1 session record.** The quality gate's AC-2 section confirms structural compliance, but checks analogous to V-4.5/V-4.6 for minor.md would complete the per-file, per-agent prompt content verification symmetry.

These are improvements for future rigor, not defects in the current test report. The existing coverage is adequate for the scope and nature of this change.

### Verdict

ADEQUATE

All 10 acceptance criteria are covered by the combined PR 1 (validated via the quality gate's independent re-validation pass) and PR 2 (37 explicit checks, all passing) test evidence. The validation methodology is correct for structural workflow file changes. Evidence is directly cited, checks test behavioral properties rather than brittle implementation details, and no checks test the wrong thing. The three recommendations above are housekeeping improvements for future cycles and do not represent defects in the current report.
